LLY |
Eli Lilly and Company |
760.49B |
5.39% |
|
|
|
|
|
802.21 |
-10.76% |
43.54% |
44.90% |
---|
PFE |
Pfizer Inc. |
135.75B |
5.28% |
|
|
|
|
|
23.94 |
-1.95% |
39.52% |
46.99% |
---|
ABBV |
AbbVie Inc. |
342.62B |
5.22% |
|
|
|
|
|
193.69 |
-0.73% |
38.23% |
57.70% |
---|
MRK |
Merck & Co., Inc. |
210.12B |
5.12% |
|
|
|
|
|
83.50 |
-2.00% |
41.05% |
63.29% |
---|
BMY |
Bristol-Myers Squibb Company |
101.15B |
5.09% |
|
|
|
|
|
49.71 |
-0.99% |
42.70% |
60.71% |
---|
ABT |
Abbott Laboratories |
227.07B |
5.05% |
|
|
|
|
|
130.93 |
0.14% |
25.82% |
29.98% |
---|
JNJ |
Johnson & Johnson |
371.82B |
4.83% |
|
|
|
|
|
154.29 |
-1.29% |
22.59% |
34.98% |
---|
AMGN |
Amgen Inc. |
152.58B |
4.64% |
|
|
|
|
|
283.80 |
-2.45% |
41.20% |
56.98% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
2.08B |
3.22% |
|
|
|
|
|
50.00 |
-3.68% |
72.63% |
25.46% |
---|
GILD |
Gilead Sciences, Inc. |
129.74B |
2.95% |
|
|
|
|
|
104.07 |
-2.32% |
38.50% |
61.83% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.79B |
2.92% |
|
|
|
|
|
32.10 |
-1.17% |
43.71% |
39.14% |
---|
LQDA |
Liquidia Corporation |
1.20B |
2.91% |
|
|
|
|
|
14.10 |
0.93% |
66.08% |
36.28% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.13B |
2.84% |
|
|
|
|
|
115.61 |
-1.15% |
31.17% |
65.04% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
1.72B |
2.79% |
|
|
|
|
|
29.93 |
1.56% |
54.28% |
68.91% |
---|
UTHR |
United Therapeutics Corporation |
13.38B |
2.77% |
|
|
|
|
|
297.99 |
-1.68% |
35.09% |
74.12% |
---|
BIIB |
Biogen Inc. |
17.81B |
2.70% |
|
|
|
|
|
121.69 |
0.50% |
46.34% |
53.16% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
62.23B |
2.69% |
|
|
|
|
|
581.89 |
-2.82% |
49.81% |
76.60% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.82B |
2.69% |
|
|
|
|
|
20.45 |
-1.73% |
77.53% |
12.19% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
859.20M |
2.68% |
|
|
|
|
|
26.74 |
-0.94% |
55.89% |
42.38% |
---|
VTRS |
Viatris Inc. |
10.19B |
2.65% |
|
|
|
|
|
8.54 |
1.37% |
30.87% |
74.08% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.53B |
2.64% |
|
|
|
|
|
7.59 |
-0.91% |
67.35% |
79.44% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.34B |
2.63% |
|
|
|
|
|
8.43 |
1.57% |
132.65% |
39.74% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
1.51B |
2.63% |
|
|
|
|
|
70.17 |
-0.92% |
50.20% |
67.44% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.06B |
2.62% |
|
|
|
|
|
82.04 |
1.00% |
28.23% |
65.20% |
---|
INVA |
Innoviva, Inc. |
1.17B |
2.59% |
|
|
|
|
|
18.58 |
-0.62% |
52.77% |
43.58% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.09B |
2.56% |
|
|
|
|
|
108.65 |
-1.10% |
51.23% |
67.38% |
---|
PRGO |
Perrigo Company plc |
3.45B |
2.55% |
|
|
|
|
|
25.27 |
-1.75% |
43.05% |
68.58% |
---|
CORT |
Corcept Therapeutics Incorporated |
7.47B |
2.52% |
|
|
|
|
|
70.81 |
-1.50% |
65.42% |
36.42% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
1.14B |
2.40% |
|
|
|
|
|
24.00 |
-1.68% |
55.34% |
75.57% |
---|
GERN |
Geron Corporation |
872.57M |
2.31% |
|
|
|
|
|
1.3700 |
-2.84% |
92.88% |
46.31% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.14% |
|
|
|
|
|
|
|
|
|
---|